A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam

NCT02233972 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: Midazolam
DRUG: Ginkgolides Meglumine Injection
DRUG: placebo

Sponsor

Jiangsu Kanion Pharmaceutical Co., Ltd